Abstract
Reactive oxygen species (ROS) are ubiquitous metabolic products and important cellular signaling molecules that contribute to several biological functions. Pathophysiology arises when ROS are generated either in excess or in cell types or subcellular locations that normally do not produce ROS or when non-physiological types of ROS (e.g., superoxide instead of hydrogen peroxide) are formed. In the latter scenario, antioxidants were considered as the apparent remedy but, clinically, have consistently failed and even sometimes induced harm. The obvious reason for that is the non-selective ROS scavenging effects of antioxidants which interfere with both qualities of ROS, physiological and pathological. Therefore, it is essential to overcome this “antidote or neutralizer” strategy. We here review the most promising alternative approach by identifying the disease-relevant enzymatic sources of ROS, target these selectively, but leave physiological ROS signaling through other sources intact. Among all ROS sources, NADPH oxidases (NOX1-5 and DUOX1-2) stand out as their sole function is to produce ROS, whereas most other enzymatic sources only produce ROS as a by-product or upon biochemical uncoupling or damage. This qualifies NOXs as the main potential drug-target candidates in diseases associated with dysfunction in ROS signaling. As a reflection of this, the development of several NOX inhibitors has taken place. Recently, the WHO approved a new stem, “naxib,” which refers to NADPH oxidase inhibitors, and thereby recognized NOX inhibitors as a new therapeutic class. This has been announced while clinical trials with the first-in-class compound, setanaxib (initially known as GKT137831) had been initiated. We also review the differences between the seven NOX family members in terms of structure and function in health and disease and then focus on the most advanced NOX inhibitors with an exclusive focus on clinically relevant validations and applications.
Graphical Abstract
Therapeutically relevant NADPH oxidase isoforms type 1, 2, 4, and 5 (NOX1, NOX2, NOX4, NOX5). Of note, NOX5 is not present in mice and rats and thus pre-clinically less studied. NOX2, formerly termed gp91phox, has been correlated with many, too many, diseases and is rather relevant as genetic deficiency in chronic granulomatous disease (CGD), treated by gene therapy. Overproduction of ROS through NOX1, NOX4, and NOX5 leads to the indicated diseases states including atherosclerosis (red), a condition where NOX4 is surprisingly protective.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abubaker AA, Vara D, Visconte C, Eggleston I, Torti M, Canobbio I, Pula G (2019) Amyloid peptide beta1-42 induces integrin alphaiibbeta3 activation, platelet adhesion, and thrombus formation in a NADPH oxidase-dependent manner. Oxidative Med Cell Longev 2019:1050476. https://doi.org/10.1155/2019/1050476
Accetta R, Damiano S, Morano A, Mondola P, Paterno R, Avvedimento EV, Santillo M (2016) Reactive oxygen species derived from NOX3 and NOX5 drive differentiation of human oligodendrocytes. Front Cell Neurosci 10:146. https://doi.org/10.3389/fncel.2016.00146
Ago T, Kuroda J, Pain J, Fu C, Li H, Sadoshima J (2010) Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res 106(7):1253–1264. https://doi.org/10.1161/CIRCRESAHA.109.213116
Aliasgharzadeh A, Farhood B, Amini P, Saffar H, Motevaseli E, Rezapoor S et al (2019) Melatonin attenuates upregulation of Duox1 and Duox2 and protects against lung injury following chest irradiation in rats. Cell J 21(3):236–242. https://doi.org/10.22074/cellj.2019.6207
Altenhofer S, Radermacher KA, Kleikers PW, Wingler K, Schmidt HH (2015) Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal 23(5):406–427. https://doi.org/10.1089/ars.2013.5814
Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP (2004) Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279(44):45935–45941. https://doi.org/10.1074/jbc.M406486200
Ameziane-El-Hassani R, Talbot M, de Souza Dos Santos MC, Al Ghuzlan A, Hartl D, Bidart JM et al (2015) NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation. Proc Natl Acad Sci U S A 112(16):5051–5056. https://doi.org/10.1073/pnas.1420707112
Antony S, Jiang G, Wu Y, Meitzler JL, Makhlouf HR, Haines DC et al (2017) NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1alpha and p27(Kip1) expression in malignant melanoma and other human tumors. Mol Carcinog 56(12):2643–2662. https://doi.org/10.1002/mc.22708
Appukuttan B, Ma Y, Stempel A, Ashander LM, Deliyanti D, Wilkinson-Berka JL, Smith JR (2018) Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells. Clin Exp Ophthalmol 46(6):652–660. https://doi.org/10.1111/ceo.13155
Augsburger F, Filippova A, Rasti D, Seredenina T, Lam M, Maghzal G et al (2019) Pharmacological characterization of the seven human NOX isoforms and their inhibitors. Redox Biol 26:101272. https://doi.org/10.1016/j.redox.2019.101272
Azmoonfar R, Amini P, Saffar H, Rezapoor S, Motevaseli E, Cheki M et al (2018) Metformin protects against radiation-induced pneumonitis and fibrosis and attenuates upregulation of dual oxidase genes expression. Adv Pharm Bull 8(4):697–704. https://doi.org/10.15171/apb.2018.078
Banfi B, Maturana A, Jaconi S, Arnaudeau S, Laforge T, Sinha B et al (2000) A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 287(5450):138–142. https://doi.org/10.1126/science.287.5450.138
Banfi B, Molnar G, Maturana A, Steger K, Hegedus B, Demaurex N, Krause KH (2001) A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 276(40):37594–37601. https://doi.org/10.1074/jbc.M103034200
Banfi B, Clark RA, Steger K, Krause KH (2003) Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278(6):3510–3513. https://doi.org/10.1074/jbc.C200613200
Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, Krause KH (2004a) NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 279(44):46065–46072. https://doi.org/10.1074/jbc.M403046200
Banfi B, Tirone F, Durussel I, Knisz J, Moskwa P, Molnar GZ et al (2004b) Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). J Biol Chem 279(18):18583–18591. https://doi.org/10.1074/jbc.M310268200
Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87(1):245–313. https://doi.org/10.1152/physrev.00044.2005
BelAiba RS, Djordjevic T, Petry A, Diemer K, Bonello S, Banfi B et al (2007) NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med 42(4):446–459. https://doi.org/10.1016/j.freeradbiomed.2006.10.054
Brandes RP, Weissmann N, Schroder K (2014) Nox family NADPH oxidases: molecular mechanisms of activation. Free Radic Biol Med 76:208–226. https://doi.org/10.1016/j.freeradbiomed.2014.07.046
Brewer AC, Murray TV, Arno M, Zhang M, Anilkumar NP, Mann GE, Shah AM (2011) Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. Free Radic Biol Med 51(1):205–215. https://doi.org/10.1016/j.freeradbiomed.2011.04.022
Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schroder E et al (2007) Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317(5843):1393–1397. https://doi.org/10.1126/science.1144318
Carnesecchi S, Deffert C, Donati Y, Basset O, Hinz B, Preynat-Seauve O et al (2011) A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid Redox Signal 15(3):607–619. https://doi.org/10.1089/ars.2010.3829
Casas AI, Dao VT, Daiber A, Maghzal GJ, Di Lisa F, Kaludercic N et al (2015) Reactive oxygen-related diseases: therapeutic targets and emerging clinical indications. Antioxid Redox Signal 23(14):1171–1185. https://doi.org/10.1089/ars.2015.6433
Casas AI, Geuss E, Kleikers PWM, Mencl S, Herrmann AM, Buendia I et al (2017) NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage. Proc Natl Acad Sci U S A 114(46):12315–12320. https://doi.org/10.1073/pnas.1705034114
Casas AI, Hassan AA, Larsen SJ, Gomez-Rangel V, Elbatreek M, Kleikers PWM et al (2019a) From single drug targets to synergistic network pharmacology in ischemic stroke. Proc Natl Acad Sci U S A 116(14):7129–7136. https://doi.org/10.1073/pnas.1820799116
Casas AI, Kleikers PW, Geuss E, Langhauser F, Adler T, Busch DH et al (2019b) Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke. J Clin Invest 130:1772–1778. https://doi.org/10.1172/JCI124283
Case AJ, Li S, Basu U, Tian J, Zimmerman MC (2013) Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons. Am J Physiol Heart Circ Physiol 305(1):H19–H28. https://doi.org/10.1152/ajpheart.00974.2012
Cha JJ, Min HS, Kim KT, Kim JE, Ghee JY, Kim HW et al (2017) APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury. Lab Investig 97(4):419–431. https://doi.org/10.1038/labinvest.2017.2
Chamulitrat W, Schmidt R, Tomakidi P, Stremmel W, Chunglok W, Kawahara T, Rokutan K (2003) Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes. Oncogene 22(38):6045–6053. https://doi.org/10.1038/sj.onc.1206654
Chen F, Pandey D, Chadli A, Catravas JD, Chen T, Fulton DJ (2011) Hsp90 regulates NADPH oxidase activity and is necessary for superoxide but not hydrogen peroxide production. Antioxid Redox Signal 14(11):2107–2119. https://doi.org/10.1089/ars.2010.3669
Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD (2001) Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269(1–2):131–140. https://doi.org/10.1016/s0378-1119(01)00449-8
Cheng G, Diebold BA, Hughes Y, Lambeth JD (2006) Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem 281(26):17718–17726. https://doi.org/10.1074/jbc.M512751200
Choi SA, Kim YH, Park YH, Yang HJ, Jeong PS, Cha JJ et al (2019) Novel crosstalk between Vps26a and Nox4 signaling during neurogenesis. Cell Death Differ 26(9):1582–1599. https://doi.org/10.1038/s41418-018-0226-0
Coant N, Ben Mkaddem S, Pedruzzi E, Guichard C, Treton X, Ducroc R et al (2010) NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol 30(11):2636–2650. https://doi.org/10.1128/MCB.01194-09
Crosas-Molist E, Bertran E, Rodriguez-Hernandez I, Herraiz C, Cantelli G, Fabra A et al (2017) The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination. Oncogene 36(21):3002–3014. https://doi.org/10.1038/onc.2016.454
Cross AR, Segal AW (2004) The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems. Biochim Biophys Acta 1657(1):1–22. https://doi.org/10.1016/j.bbabio.2004.03.008
Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu D (2005) NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97(9):900–907. https://doi.org/10.1161/01.RES.0000187457.24338.3D
Cui XL, Brockman D, Campos B, Myatt L (2006) Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27(4–5):422–431. https://doi.org/10.1016/j.placenta.2005.04.004
Dao VT, Casas AI, Maghzal GJ, Seredenina T, Kaludercic N, Robledinos-Anton N et al (2015) Pharmacology and clinical drug candidates in redox medicine. Antioxid Redox Signal 23(14):1113–1129. https://doi.org/10.1089/ars.2015.6430
Dao VT, Elbatreek MH, Altenhofer S, Casas AI, Pachado MP, Neullens CT et al (2019) Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation. Free Radic Biol Med 148:60–69. https://doi.org/10.1016/j.freeradbiomed.2019.12.038
De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G et al (2000) Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275(30):23227–23233. https://doi.org/10.1074/jbc.M000916200
De Deken X, Wang D, Dumont JE, Miot F (2002) Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. Exp Cell Res 273(2):187–196. https://doi.org/10.1006/excr.2001.5444
Den Hartigh LJ, Omer M, Goodspeed L, Wang S, Wietecha T, O’Brien KD, Han CY (2017) Adipocyte-specific deficiency of NADPH oxidase 4 delays the onset of insulin resistance and attenuates adipose tissue inflammation in obesity. Arterioscler Thromb Vasc Biol 37(3):466–475. https://doi.org/10.1161/ATVBAHA.116.308749
Dhukhwa A, Bhatta P, Sheth S, Korrapati K, Tieu C, Mamillapalli C et al (2019) Targeting inflammatory processes mediated by TRPVI and TNF-alpha for treating noise-induced hearing loss. Front Cell Neurosci 13:444. https://doi.org/10.3389/fncel.2019.00444
Diebold BA, Bokoch GM (2001) Molecular basis for Rac2 regulation of phagocyte NADPH oxidase. Nat Immunol 2(3):211–215. https://doi.org/10.1038/85259
Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG (2000) Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86(3):347–354. https://doi.org/10.1161/01.res.86.3.347
El Hassani RA, Benfares N, Caillou B, Talbot M, Sabourin JC, Belotte V et al (2005) Dual oxidase2 is expressed all along the digestive tract. Am J Physiol Gastrointest Liver Physiol 288(5):G933–G942. https://doi.org/10.1152/ajpgi.00198.2004
Elbatreek MH, Pachado MP, Cuadrado A, Jandeleit-Dahm K, Schmidt H (2019) Reactive oxygen comes of age: mechanism-based therapy of diabetic end-organ damage. Trends Endocrinol Metab 30(5):312–327. https://doi.org/10.1016/j.tem.2019.02.006
Escors D, Breckpot K (2010) Lentiviral vectors in gene therapy: their current status and future potential. Arch Immunol Ther Exp 58(2):107–119. https://doi.org/10.1007/s00005-010-0063-4
Fan LM, Geng L, Cahill-Smith S, Liu F, Douglas G, McKenzie CA et al (2019) Nox2 contributes to age-related oxidative damage to neurons and the cerebral vasculature. J Clin Invest 129(8):3374–3386. https://doi.org/10.1172/JCI125173
Farhood B, Aliasgharzadeh A, Amini P, Saffar H, Motevaseli E, Rezapoor S et al (2019) Radiation-induced dual oxidase upregulation in rat heart tissues: protective effect of melatonin. Medicina 55(7):317. https://doi.org/10.3390/medicina55070317
Feraille E, Dizin E, Roth I, Derouette JP, Szanto I, Martin PY et al (2014) NADPH oxidase 4 deficiency reduces aquaporin-2 mRNA expression in cultured renal collecting duct principal cells via increased PDE3 and PDE4 activity. PLoS One 9(1):e87239. https://doi.org/10.1371/journal.pone.0087239
Fischer H (2009) Mechanisms and function of DUOX in epithelia of the lung. Antioxid Redox Signal 11(10):2453–2465. https://doi.org/10.1089/ARS.2009.2558
Fulton DJ (2009) Nox5 and the regulation of cellular function. Antioxid Redox Signal 11(10):2443–2452. https://doi.org/10.1089/ars.2009.2587
Geiszt M, Kopp JB, Varnai P, Leto TL (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97(14):8010–8014. https://doi.org/10.1073/pnas.130135897
Geiszt M, Lekstrom K, Brenner S, Hewitt SM, Dana R, Malech HL, Leto TL (2003a) NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J Immunol 171(1):299–306. https://doi.org/10.4049/jimmunol.171.1.299
Geiszt M, Witta J, Baffi J, Lekstrom K, Leto TL (2003b) Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 17(11):1502–1504. https://doi.org/10.1096/fj.02-1104fje
Ghanbari H, Keshtgar S, Kazeroni M (2018) Inhibition of the CatSper channel and NOX5 enzyme activity affects the functions of the progesterone-stimulated human sperm. Iran J Med Sci 43(1):18–25
Giardino G, Cicalese MP, Delmonte O, Migliavacca M, Palterer B, Loffredo L et al (2017) NADPH oxidase deficiency: a multisystem approach. Oxidative Med Cell Longev 2017:4590127. https://doi.org/10.1155/2017/4590127
Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, Abboud HE (2003) Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285(2):F219–F229. https://doi.org/10.1152/ajprenal.00414.2002
Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R (2000) A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87(1):26–32. https://doi.org/10.1161/01.res.87.1.26
Grasberger H, Refetoff S (2006) Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J Biol Chem 281(27):18269–18272. https://doi.org/10.1074/jbc.C600095200
Gray SP, Di Marco E, Okabe J, Szyndralewiez C, Heitz F, Montezano AC et al (2013) NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 127(18):1888–1902. https://doi.org/10.1161/CIRCULATIONAHA.112.132159
Gray SP, Di Marco E, Kennedy K, Chew P, Okabe J, El-Osta A et al (2016) Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling. Arterioscler Thromb Vasc Biol 36(2):295–307. https://doi.org/10.1161/ATVBAHA.115.307012
Gray SP, Jha JC, Kennedy K, van Bommel E, Chew P, Szyndralewiez C et al (2017) Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease. Diabetologia 60(5):927–937. https://doi.org/10.1007/s00125-017-4215-5
Guo S, Chen X (2015) The human Nox4: gene, structure, physiological function and pathological significance. J Drug Target 23(10):888–896. https://doi.org/10.3109/1061186X.2015.1036276
Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D et al (2008) Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol 52(22):1803–1809. https://doi.org/10.1016/j.jacc.2008.07.063
Guzik B, Sagan A, Ludew D, Mrowiecki W, Chwala M, Bujak-Gizycka B et al (2013) Mechanisms of oxidative stress in human aortic aneurysms--association with clinical risk factors for atherosclerosis and disease severity. Int J Cardiol 168(3):2389–2396. https://doi.org/10.1016/j.ijcard.2013.01.278
Hahn NE, Meischl C, Kawahara T, Musters RJ, Verhoef VM, van der Velden J et al (2012) NOX5 expression is increased in intramyocardial blood vessels and cardiomyocytes after acute myocardial infarction in humans. Am J Pathol 180(6):2222–2229. https://doi.org/10.1016/j.ajpath.2012.02.018
Haque MZ, Majid DS (2004) Assessment of renal functional phenotype in mice lacking gp91PHOX subunit of NAD(P)H oxidase. Hypertension 43(2):335–340. https://doi.org/10.1161/01.HYP.0000111137.15873.4a
Hayes P, Dhillon S, O’Neill K, Thoeni C, Hui KY, Elkadri A et al (2015) Defects in NADPH oxidase genes NOX1 and DUOX2 in very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol 1(5):489–502. https://doi.org/10.1016/j.jcmgh.2015.06.005
He W, Wang Q, Gu L, Zhong L, Liu D (2018) NOX4 rs11018628 polymorphism associates with a decreased risk and better short-term recovery of ischemic stroke. Exp Ther Med 16(6):5258–5264. https://doi.org/10.3892/etm.2018.6874
Henriquez-Olguin C, Boronat S, Cabello-Verrugio C, Jaimovich E, Hidalgo E, Jensen TE (2019) The emerging roles of nicotinamide adenine dinucleotide phosphate oxidase 2 in skeletal muscle redox signaling and metabolism. Antioxid Redox Signal 31(18):1371–1410. https://doi.org/10.1089/ars.2018.7678
Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK (2004) Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24(4):677–683. https://doi.org/10.1161/01.ATV.0000112024.13727.2c
Hirano K, Chen WS, Chueng AL, Dunne AA, Seredenina T, Filippova A et al (2015) Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor. Antioxid Redox Signal 23(5):358–374. https://doi.org/10.1089/ars.2014.6202
Hoidal JR, Brar SS, Sturrock AB, Sanders KA, Dinger B, Fidone S, Kennedy TP (2003) The role of endogenous NADPH oxidases in airway and pulmonary vascular smooth muscle function. Antioxid Redox Signal 5(6):751–758. https://doi.org/10.1089/152308603770380052
Holterman CE, Thibodeau JF, Towaij C, Gutsol A, Montezano AC, Parks RJ et al (2014) Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression. J Am Soc Nephrol 25(4):784–797. https://doi.org/10.1681/ASN.2013040371
Huang J, Hitt ND, Kleinberg ME (1995) Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558. Biochemistry 34(51):16753–16757. https://doi.org/10.1021/bi00051a024
Ibi M, Katsuyama M, Fan C, Iwata K, Nishinaka T, Yokoyama T, Yabe-Nishimura C (2006) NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth. Free Radic Biol Med 40(10):1785–1795. https://doi.org/10.1016/j.freeradbiomed.2006.01.009
Iles KE, Forman HJ (2002) Macrophage signaling and respiratory burst. Immunol Res 26(1–3):95–105. https://doi.org/10.1385/IR:26:1-3:095
Janiszewski M, Lopes LR, Carmo AO, Pedro MA, Brandes RP, Santos CX, Laurindo FR (2005) Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 280(49):40813–40819. https://doi.org/10.1074/jbc.M509255200
Jay DB, Papaharalambus CA, Seidel-Rogol B, Dikalova AE, Lassegue B, Griendling KK (2008) Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic Biol Med 45(3):329–335. https://doi.org/10.1016/j.freeradbiomed.2008.04.024
Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T et al (2014) Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol 25(6):1237–1254. https://doi.org/10.1681/ASN.2013070810
Jha JC, Thallas-Bonke V, Banal C, Gray SP, Chow BS, Ramm G et al (2016) Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Diabetologia 59(2):379–389. https://doi.org/10.1007/s00125-015-3796-0
Jha JC, Banal C, Okabe J, Gray SP, Hettige T, Chow BSM et al (2017a) NADPH oxidase Nox5 accelerates renal injury in diabetic nephropathy. Diabetes 66(10):2691–2703. https://doi.org/10.2337/db16-1585
Jha JC, Banal C, Okabe J, Gray SP, Hettige T, Chow BSM et al (2017b) NADPH oxidase Nox5 accelerates renal injury in diabetic nephropathy. Diabetes 66(10):2691–2703. https://doi.org/10.2337/db16-1585
Jiang F, Zhang Y, Dusting GJ (2011) NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev 63(1):218–242. https://doi.org/10.1124/pr.110.002980
Jiao W, Ji J, Li F, Guo J, Zheng Y, Li S, Xu W (2019) Activation of the NotchNox4reactive oxygen species signaling pathway induces cell death in high glucose treated human retinal endothelial cells. Mol Med Rep 19(1):667–677. https://doi.org/10.3892/mmr.2018.9637
Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G et al (2017) NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem 292(19):7866–7887. https://doi.org/10.1074/jbc.M116.768283
Kajla S, Mondol AS, Nagasawa A, Zhang Y, Kato M, Matsuno K et al (2012) A crucial role for Nox 1 in redox-dependent regulation of Wnt-beta-catenin signaling. FASEB J 26(5):2049–2059. https://doi.org/10.1096/fj.11-196360
Kang HJ, Bartholomae CC, Paruzynski A, Arens A, Kim S, Yu SS et al (2011a) Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial. Mol Ther 19(11):2092–2101. https://doi.org/10.1038/mt.2011.166
Kang EM, Marciano BE, DeRavin S, Zarember KA, Holland SM, Malech HL (2011b) Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol 127(6):1319–1326.; quiz 1327-1318. https://doi.org/10.1016/j.jaci.2011.03.028
Kato K, Hecker L (2020) NADPH oxidases: pathophysiology and therapeutic potential in age-associated pulmonary fibrosis. Redox Biol 33:101541. https://doi.org/10.1016/j.redox.2020.101541
Kato M, Marumo M, Nakayama J, Matsumoto M, Yabe-Nishimura C, Kamata T (2016) The ROS-generating oxidase Nox1 is required for epithelial restitution following colitis. Exp Anim 65(3):197–205. https://doi.org/10.1538/expanim.15-0127
Keller MD, Notarangelo LD, Malech HL (2018) Future of care for patients with chronic granulomatous disease: gene therapy and targeted molecular medicine. J Pediatric Infect Dis Soc 7(suppl_1):S40–S44. https://doi.org/10.1093/jpids/piy011
Kishida KT, Hoeffer CA, Hu D, Pao M, Holland SM, Klann E (2006) Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol Cell Biol 26(15):5908–5920. https://doi.org/10.1128/MCB.00269-06
Kleikers PW, Hooijmans C, Gob E, Langhauser F, Rewell SS, Radermacher K et al (2015) A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation. Sci Rep 5:13428. https://doi.org/10.1038/srep13428
Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M et al (2010) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 8(9):e1000479. https://doi.org/10.1371/journal.pbio.1000479
Ko E, Choi H, Kim B, Kim M, Park KN, Bae IH et al (2014) Testosterone stimulates Duox1 activity through GPRC6A in skin keratinocytes. J Biol Chem 289(42):28835–28845. https://doi.org/10.1074/jbc.M114.583450
Kohn DB, Booth C, Kang EM, Pai SY, Shaw KL, Santilli G et al (2020) Lentiviral gene therapy for X-linked chronic granulomatous disease. Nat Med 26(2):200–206. https://doi.org/10.1038/s41591-019-0735-5
Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H et al (2007) ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 14(2):230–239. https://doi.org/10.1038/sj.cdd.4401984
Krijnen PA, Meischl C, Hack CE, Meijer CJ, Visser CA, Roos D, Niessen HW (2003) Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol 56(3):194–199. https://doi.org/10.1136/jcp.56.3.194
Lan T, Kisseleva T, Brenner DA (2015) Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation. PLoS One 10(7):e0129743. https://doi.org/10.1371/journal.pone.0129743
Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y et al (2001) Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88(9):888–894. https://doi.org/10.1161/hh0901.090299
Laurent E, McCoy JW 3rd, Macina RA, Liu W, Cheng G, Robine S et al (2008) Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras. Int J Cancer 123(1):100–107. https://doi.org/10.1002/ijc.23423
Lee SR, An EJ, Kim J, Bae YS (2020) Function of NADPH oxidases in diabetic nephropathy and development of nox inhibitors. Biomol Ther 28(1):25–33. https://doi.org/10.4062/biomolther.2019.188
Li T, Luo XJ, Wang EL, Li NS, Zhang XJ, Song FL et al (2019) Magnesium lithospermate B prevents phenotypic transformation of pulmonary arteries in rats with hypoxic pulmonary hypertension through suppression of NADPH oxidase. Eur J Pharmacol 847:32–41. https://doi.org/10.1016/j.ejphar.2019.01.020
Lin XL, Yang L, Fu SW, Lin WF, Gao YJ, Chen HY, Ge ZZ (2017) Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer. Oncotarget 8(20):33586–33600. https://doi.org/10.18632/oncotarget.16829
Lu X, Wang F, Liu M, Yang KT, Nau A, Kohan DE et al (2016) Activation of ENaC in collecting duct cells by prorenin and its receptor PRR: involvement of Nox4-derived hydrogen peroxide. Am J Physiol Renal Physiol 310(11):F1243–F1250. https://doi.org/10.1152/ajprenal.00492.2015
Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P et al (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105(3):249–259. https://doi.org/10.1161/CIRCRESAHA.109.193722
Mahadev K, Motoshima H, Wu X, Ruddy JM, Arnold RS, Cheng G et al (2004) The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol 24(5):1844–1854. https://doi.org/10.1128/mcb.24.5.1844-1854.2004
Manea A, Raicu M, Simionescu M (2005) Expression of functionally phagocyte-type NAD(P)H oxidase in pericytes: effect of angiotensin II and high glucose. Biol Cell 97(9):723–734. https://doi.org/10.1042/BC20040107
Manea A, Manea SA, Gan AM, Constantin A, Fenyo IM, Raicu M et al (2015) Human monocytes and macrophages express NADPH oxidase 5; a potential source of reactive oxygen species in atherosclerosis. Biochem Biophys Res Commun 461(1):172–179. https://doi.org/10.1016/j.bbrc.2015.04.021
Marzaioli V, Hurtado-Nedelec M, Pintard C, Tlili A, Marie JC, Monteiro RC et al (2017) NOX5 and p22phox are 2 novel regulators of human monocytic differentiation into dendritic cells. Blood 130(15):1734–1745. https://doi.org/10.1182/blood-2016-10-746347
Matsushima S, Kuroda J, Ago T, Zhai P, Park JY, Xie LH et al (2013) Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res 112(4):651–663. https://doi.org/10.1161/CIRCRESAHA.112.279760
Meitzler JL, Ortiz de Montellano PR (2009) Caenorhabditis elegans and human dual oxidase 1 (DUOX1) "peroxidase" domains: insights into heme binding and catalytic activity. J Biol Chem 284(28):18634–18643. https://doi.org/10.1074/jbc.M109.013581
Meitzler JL, Ortiz de Montellano PR (2011) Structural stability and heme binding potential of the truncated human dual oxidase 2 (DUOX2) peroxidase domain. Arch Biochem Biophys 512(2):197–203. https://doi.org/10.1016/j.abb.2011.05.021
Miller CH, Maher SG, Young HA (2009) Clinical use of interferon-gamma. Ann N Y Acad Sci 1182:69–79. https://doi.org/10.1111/j.1749-6632.2009.05069.x
Moll F, Walter M, Rezende F, Helfinger V, Vasconez E, De Oliveira T et al (2018) NoxO1 controls proliferation of colon epithelial cells. Front Immunol 9:973. https://doi.org/10.3389/fimmu.2018.00973
Mongue-Din H, Patel AS, Looi YH, Grieve DJ, Anilkumar N, Sirker A et al (2017) NADPH oxidase-4 driven cardiac macrophage polarization protects against myocardial infarction-induced remodeling. JACC Basic Transl Sci 2(6):688–698. https://doi.org/10.1016/j.jacbts.2017.06.006
Montezano AC, De Lucca Camargo L, Persson P, Rios FJ, Harvey AP, Anagnostopoulou A et al (2018) NADPH oxidase 5 is a pro-contractile nox isoform and a point of cross-talk for calcium and redox signaling-implications in vascular function. J Am Heart Assoc 7(12):e009388. https://doi.org/10.1161/JAHA.118.009388
Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, de Vijlder JJ et al (2002) Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 347(2):95–102. https://doi.org/10.1056/NEJMoa012752
Nakano Y, Banfi B, Jesaitis AJ, Dinauer MC, Allen LA, Nauseef WM (2007) Critical roles for p22phox in the structural maturation and subcellular targeting of Nox3. Biochem J 403(1):97–108. https://doi.org/10.1042/BJ20060819
Nlandu Khodo S, Dizin E, Sossauer G, Szanto I, Martin PY, Feraille E et al (2012) NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J Am Soc Nephrol 23(12):1967–1976. https://doi.org/10.1681/ASN.2012040373
O’Neill S, Brault J, Stasia MJ, Knaus UG (2015) Genetic disorders coupled to ROS deficiency. Redox Biol 6:135–156. https://doi.org/10.1016/j.redox.2015.07.009
Paffenholz R, Bergstrom RA, Pasutto F, Wabnitz P, Munroe RJ, Jagla W et al (2004) Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev 18(5):486–491. https://doi.org/10.1101/gad.1172504
Panday A, Sahoo MK, Osorio D, Batra S (2015) NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol 12(1):5–23. https://doi.org/10.1038/cmi.2014.89
Pao M, Wiggs EA, Anastacio MM, Hyun J, DeCarlo ES, Miller JT et al (2004) Cognitive function in patients with chronic granulomatous disease: a preliminary report. Psychosomatics 45(3):230–234. https://doi.org/10.1176/appi.psy.45.3.230
Parkos CA, Allen RA, Cochrane CG, Jesaitis AJ (1987) Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest 80(3):732–742. https://doi.org/10.1172/JCI113128
Perrotta I, Sciangula A, Perrotta E, Donato G, Cassese M (2011) Ultrastructural analysis and electron microscopic localization of Nox4 in healthy and atherosclerotic human aorta. Ultrastruct Pathol 35(1):1–6. https://doi.org/10.3109/01913123.2010.510261
Plecita-Hlavata L, Jaburek M, Holendova B, Tauber J, Pavluch V, Berkova Z et al (2020) Glucose-stimulated insulin secretion fundamentally requires H2O2 signaling by NADPH oxidase 4. Diabetes 7(12):e009388. https://doi.org/10.2337/db19-1130
Reinehr R, Becker S, Eberle A, Grether-Beck S, Haussinger D (2005) Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280(29):27179–27194. https://doi.org/10.1074/jbc.M414361200
Rezende F, Schurmann C, Schutz S, Harenkamp S, Herrmann E, Seimetz M et al (2017) Knock out of the NADPH oxidase Nox4 has no impact on life span in mice. Redox Biol 11:312–314. https://doi.org/10.1016/j.redox.2016.12.012
Rigutto S, Hoste C, Grasberger H, Milenkovic M, Communi D, Dumont JE et al (2009) Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation. J Biol Chem 284(11):6725–6734. https://doi.org/10.1074/jbc.M806893200
Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Sekiyama A, Teshima-Kondo S (2006) NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid Redox Signal 8(9–10):1573–1582. https://doi.org/10.1089/ars.2006.8.1573
Rossi F, Zatti M (1964) Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 20(1):21–23. https://doi.org/10.1007/bf02146019
Rybak LP, Mukherjea D, Jajoo S, Kaur T, Ramkumar V (2012) siRNA-mediated knock-down of NOX3: therapy for hearing loss? Cell Mol Life Sci 69(14):2429–2434. https://doi.org/10.1007/s00018-012-1016-3
Scherz-Shouval R, Elazar Z (2011) Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36(1):30–38. https://doi.org/10.1016/j.tibs.2010.07.007
Schroder K, Wandzioch K, Helmcke I, Brandes RP (2009) Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler Thromb Vasc Biol 29(2):239–245. https://doi.org/10.1161/ATVBAHA.108.174219
Schroder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J et al (2012) Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110(9):1217–1225. https://doi.org/10.1161/circresaha.112.267054
Schurmann C, Rezende F, Kruse C, Yasar Y, Lowe O, Fork C et al (2015) The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur Heart J 36(48):3447–3456. https://doi.org/10.1093/eurheartj/ehv460
Schwarzer C, Machen TE, Illek B, Fischer H (2004) NADPH oxidase-dependent acid production in airway epithelial cells. J Biol Chem 279(35):36454–36461. https://doi.org/10.1074/jbc.M404983200
Schwerd T, Bryant RV, Pandey S, Capitani M, Meran L, Cazier JB et al (2018) NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol 11(2):562–574. https://doi.org/10.1038/mi.2017.74
Segal AW, Jones OT (1978) Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature 276(5687):515–517. https://doi.org/10.1038/276515a0
Seredenina T, Chiriano G, Filippova A, Nayernia Z, Mahiout Z, Fioraso-Cartier L et al (2015) A subset of N-substituted phenothiazines inhibits NADPH oxidases. Free Radic Biol Med 86:239–249. https://doi.org/10.1016/j.freeradbiomed.2015.05.023
Seredenina T, Nayernia Z, Sorce S, Maghzal GJ, Filippova A, Ling SC et al (2016) Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 97:95–108. https://doi.org/10.1016/j.freeradbiomed.2016.05.016
Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D et al (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401(6748):79–82. https://doi.org/10.1038/43459
Sun Q, Zhang W, Zhong W, Sun X, Zhou Z (2017) Pharmacological inhibition of NOX4 ameliorates alcohol-induced liver injury in mice through improving oxidative stress and mitochondrial function. Biochim Biophys Acta Gen Subj 1861(1 Pt A):2912–2921. https://doi.org/10.1016/j.bbagen.2016.09.009
Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E et al (2005) Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207(2):164–176. https://doi.org/10.1002/path.1824
Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7(2):85–96. https://doi.org/10.1038/nrm1837
Teshima S, Kutsumi H, Kawahara T, Kishi K, Rokutan K (2000) Regulation of growth and apoptosis of cultured Guinea pig gastric mucosal cells by mitogenic oxidase 1. Am J Physiol Gastrointest Liver Physiol 279(6):G1169–G1176. https://doi.org/10.1152/ajpgi.2000.279.6.G1169
Thornhill SI, Schambach A, Howe SJ, Ulaganathan M, Grassman E, Williams D et al (2008) Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Mol Ther 16(3):590–598. https://doi.org/10.1038/sj.mt.6300393
Touyz RM, Anagnostopoulou A, Camargo LL, Rios FJ, Montezano AC (2019) Vascular biology of superoxide-generating NADPH oxidase 5-implications in hypertension and cardiovascular disease. Antioxid Redox Signal 30(7):1027–1040. https://doi.org/10.1089/ars.2018.7583
Ueno N, Takeya R, Miyano K, Kikuchi H, Sumimoto H (2005) The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J Biol Chem 280(24):23328–23339. https://doi.org/10.1074/jbc.M414548200
Ueyama T, Geiszt M, Leto TL (2006) Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases. Mol Cell Biol 26(6):2160–2174. https://doi.org/10.1128/MCB.26.6.2160-2174.2006
Van Buul JD, Fernandez-Borja M, Anthony EC, Hordijk PL (2005) Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 7(3–4):308–317. https://doi.org/10.1089/ars.2005.7.308
van der Vliet A, Danyal K, Heppner DE (2018) Dual oxidase: a novel therapeutic target in allergic disease. Br J Pharmacol 175(9):1401–1418. https://doi.org/10.1111/bph.14158
Veal E, Day A (2011) Hydrogen peroxide as a signaling molecule. Antioxid Redox Signal 15(1):147–151. https://doi.org/10.1089/ars.2011.3968
Volpp BD, Nauseef WM, Clark RA (1988) Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 242(4883):1295–1297. https://doi.org/10.1126/science.2848318
Wang D, De Deken X, Milenkovic M, Song Y, Pirson I, Dumont JE, Miot F (2005) Identification of a novel partner of duox: EFP1, a thioredoxin-related protein. J Biol Chem 280(4):3096–3103. https://doi.org/10.1074/jbc.M407709200
Wang X, Elksnis A, Wikstrom P, Walum E, Welsh N, Carlsson PO (2018) The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro. PLoS One 13(9):e0204271. https://doi.org/10.1371/journal.pone.0204271
Wang FT, Hassan M, Ansari KH, Xu GL, Li XP, Fan YZ (2019) Upregulated NOX1 expression in gallbladder cancer-associated fibroblasts predicts a poor prognosis. Oncol Rep 42(4):1475–1486
Wientjes FB, Hsuan JJ, Totty NF, Segal AW (1993) p40phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem J 296(Pt 3):557–561. https://doi.org/10.1042/bj2960557
Wilkinson-Berka JL, Deliyanti D, Rana I, Miller AG, Agrotis A, Armani R et al (2013) NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy. Antioxid Redox Signal 20(17):2726–2740. https://doi.org/10.1089/ars.2013.5357
Wilkinson-Berka JL, Deliyanti D, Rana I, Miller AG, Agrotis A, Armani R et al (2014) NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy. Antioxid Redox Signal 20(17):2726–2740. https://doi.org/10.1089/ars.2013.5357
Won SJ, Tang XN, Suh SW, Yenari MA, Swanson RA (2011) Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by increasing superoxide production. Ann Neurol 70(4):583–590. https://doi.org/10.1002/ana.22538
Woo HA, Yim SH, Shin DH, Kang D, Yu DY, Rhee SG (2010) Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell 140(4):517–528. https://doi.org/10.1016/j.cell.2010.01.009
Wu RF, Ma Z, Liu Z, Terada LS (2010) Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation. Mol Cell Biol 30(14):3553–3568. https://doi.org/10.1128/MCB.01445-09
Xia D, Halder B, Godoy C, Chakraborty A, Singla B, Thomas E et al (2019) NADPH oxidase 1 mediates caerulein-induced pancreatic fibrosis in chronic pancreatitis. Free Radic Biol Med 147:139–149. https://doi.org/10.1016/j.freeradbiomed.2019.11.034
Yin C, Li K, Yu Y, Huang H, Yu Y, Wang Z et al (2018) Genome-wide association study identifies loci and candidate genes for non-idiopathic pulmonary hypertension in Eastern Chinese Han population. BMC Pulm Med 18(1):158. https://doi.org/10.1186/s12890-018-0719-0
Yoshikawa Y, Ago T, Kuroda J, Wakisaka Y, Tachibana M, Komori M et al (2019) Nox4 promotes neural stem/precursor cell proliferation and neurogenesis in the hippocampus and restores memory function following trimethyltin-induced injury. Neuroscience 398:193–205. https://doi.org/10.1016/j.neuroscience.2018.11.046
Yu P, Han W, Villar VA, Yang Y, Lu Q, Lee H et al (2014) Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells. Redox Biol 2:570–579. https://doi.org/10.1016/j.redox.2014.01.020
Zeng SY, Yang L, Yan QJ, Gao L, Lu HQ, Yan PK (2019) Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction. Biomed Pharmacother 109:1907–1914. https://doi.org/10.1016/j.biopha.2018.11.077
Zhang Y, Murugesan P, Huang K, Cai H (2019) NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat Rev Cardiol 17(3):170–194. https://doi.org/10.1038/s41569-019-0260-8
Zhao QD, Viswanadhapalli S, Williams P, Shi Q, Tan C, Yi X et al (2015) NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFkappaB signaling pathways. Circulation 131(7):643–655. https://doi.org/10.1161/CIRCULATIONAHA.114.011079
Zhao T, Wang Y, Li Z, Xu X, Lei S, Huang L et al (2020) Associations of noise kurtosis, genetic variations in NOX3 and lifestyle factors with noise-induced hearing loss. Environ Health 19(1):13. https://doi.org/10.1186/s12940-020-0566-3
Acknowledgments
This review project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 777111 (REPO-TRIAL). This reflects only the author’s view, and the European Commission is not responsible for any use that may be made of the information it contains.
Conflict of Interest
None
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Elbatreek, M.H., Mucke, H., Schmidt, H.H.H.W. (2020). NOX Inhibitors: From Bench to Naxibs to Bedside. In: Schmidt, H.H.H.W., Ghezzi, P., Cuadrado, A. (eds) Reactive Oxygen Species . Handbook of Experimental Pharmacology, vol 264. Springer, Cham. https://doi.org/10.1007/164_2020_387
Download citation
DOI: https://doi.org/10.1007/164_2020_387
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-68509-6
Online ISBN: 978-3-030-68510-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)